|1.||Piomelli, Daniele: 7 articles (08/2015 - 11/2002)|
|2.||Rodríguez de Fonseca, Fernando: 6 articles (04/2015 - 11/2002)|
|3.||Fu, Jin: 3 articles (03/2015 - 07/2004)|
|4.||Serrano, Antonia: 3 articles (01/2015 - 09/2012)|
|5.||Leweke, F Markus: 3 articles (11/2014 - 03/2009)|
|6.||Di Marzo, Vincenzo: 3 articles (09/2014 - 05/2004)|
|7.||Oveisi, Fariba: 3 articles (08/2006 - 07/2004)|
|8.||Mor, Marco: 2 articles (08/2015 - 08/2006)|
|9.||Maccarrone, Mauro: 2 articles (08/2015 - 03/2013)|
|10.||Tarzia, Giorgio: 2 articles (08/2015 - 08/2006)|
02/01/2014 - "Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson´s disease."
01/01/2015 - "Additional benefits provided by cannabinoid related compounds including CE-178253, oleoylethanolamide, nabilone and HU-210 have been reported to possess efficacy against bradykinesia and levodopa-induced dyskinesia in PD. "
11/01/2014 - "Similarly, we found significant interactions between oleoylethanolamide levels and obesity on food-related brain activation in cortical areas associated with reward processing and interoceptive signaling (P = .009). "
11/01/2014 - "Interactions between plasma oleoylethanolamide levels and obesity on BMI and functional magnetic resonance imaging response to food stimuli. "
11/01/2014 - "Oleoylethanolamide and human neural responses to food stimuli in obesity."
12/15/2006 - "The GPR119 was recently shown to be activated by oleoylethanolamide (OEA), a naturally occurring bioactive lipid with hypophagic and anti-obesity effects. "
11/01/2014 - "This study suggests that oleoylethanolamide-mediated signaling plays an important role for hedonic regulation of food craving and obesity in humans and thus may be a valuable target for developing novel antiobesity drugs."
03/01/2009 - "Thus, our results suggest that oleoylethanolamide release may represent an endogenous neuroprotective signal during sleep deprivation."
03/01/2009 - "We found increased levels of oleoylethanolamide in CSF (P = 0.011) but not in serum (P = 0.068) after 24 h of sleep deprivation. "
03/01/2009 - "Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid."
03/01/2009 - "This study investigated the role of two fatty acid ethanolamides, the endogenous cannabinoid anandamide and its structural analog oleoylethanolamide in sleep deprivation of human volunteers. "
03/01/2013 - "The objective of the study was to quantify the plasma levels of endocannabinoids (anandamide, oleoylethanolamide, and palmitoylethanolamide) and evaluate blood endocannabinoid metabolizing enzyme activities FAAH and N-acyl-phosphatidyl-ethanolamine phospholipase D (NAPE-PLD) in ectopic pregnancy and normal pregnant controls and relate that to β-human chorionic gonadotropin (β-hCG) levels. "
|1.||Levodopa (L Dopa)
|2.||HU 211 (HU 210)
|9.||Anti-Obesity Agents (Antiobesity Drugs)
|10.||Reactive Oxygen Species (Oxygen Radicals)
|1.||Gastric Bypass (Roux-en-Y Gastric Bypass)